ATE112171T1 - Uv-induzierter faktor für immununterdrückung. - Google Patents

Uv-induzierter faktor für immununterdrückung.

Info

Publication number
ATE112171T1
ATE112171T1 AT90905146T AT90905146T ATE112171T1 AT E112171 T1 ATE112171 T1 AT E112171T1 AT 90905146 T AT90905146 T AT 90905146T AT 90905146 T AT90905146 T AT 90905146T AT E112171 T1 ATE112171 T1 AT E112171T1
Authority
AT
Austria
Prior art keywords
radiation
mammal
uvb
uva
particular alloantigen
Prior art date
Application number
AT90905146T
Other languages
English (en)
Inventor
Stephen E Ullrich
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE112171T1 publication Critical patent/ATE112171T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT90905146T 1989-03-14 1990-03-14 Uv-induzierter faktor für immununterdrückung. ATE112171T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32361589A 1989-03-14 1989-03-14

Publications (1)

Publication Number Publication Date
ATE112171T1 true ATE112171T1 (de) 1994-10-15

Family

ID=23259963

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905146T ATE112171T1 (de) 1989-03-14 1990-03-14 Uv-induzierter faktor für immununterdrückung.

Country Status (6)

Country Link
EP (1) EP0489732B1 (de)
JP (1) JPH04504574A (de)
AT (1) ATE112171T1 (de)
AU (1) AU630184B2 (de)
DE (1) DE69013002T2 (de)
WO (1) WO1990010461A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910309A (en) * 1989-03-14 1999-06-08 Board Of Regents, The University Of Texas System UV-induced factor for immunosuppression
WO1994004128A2 (de) * 1992-08-26 1994-03-03 Beiersdorf Ag Verwendung von radikalfängern als immunmodulierende agentien in kosmetischen und dermatologischen zubereitungen
US11247067B2 (en) 2020-03-11 2022-02-15 Chine, Llc Apparatus and methods for phototherapy

Also Published As

Publication number Publication date
JPH04504574A (ja) 1992-08-13
WO1990010461A1 (en) 1990-09-20
DE69013002T2 (de) 1995-02-02
EP0489732A1 (de) 1992-06-17
AU630184B2 (en) 1992-10-22
DE69013002D1 (de) 1994-11-03
EP0489732B1 (de) 1994-09-28
AU5330290A (en) 1990-10-09

Similar Documents

Publication Publication Date Title
Noonan et al. Suppression of contact hypersensitivity by UV radiation and its relationship to UV‐induced suppression of tumor immunity
ATE198621T1 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
WO2002006875A8 (en) Accelerated method for increasing the photosensitivity of a glassy material
BR9303946A (pt) Macromolécula dendrítica e preparação da mesma
ATE200829T1 (de) Photolithographisches verarbeitungsverfahren und vorrichtung
Wales et al. Biochemistry of irradiated parasite vaccines: suggested models for their mode of action
ATE112171T1 (de) Uv-induzierter faktor für immununterdrückung.
DE3789781D1 (de) Antigene, Antikörper und Verfahren zur Identifizierung humaner metastatischer Tumoren und Zellinien zur Herstellung dieser Antikörper.
Robertst et al. Ultraviolet spectral energy differences affect the ability of sunscreen lotions to prevent ultraviolet‐radiation‐induced immunosuppression
DE69518579D1 (de) Verfahren zum Bleichen von Haaren durch Bestrahlung mit einem Laser, sowie die Vorrichtung
SE9603095L (sv) Förfarande för detektering av cancer i hud på människor och däggdjur samt anordning för utövande av förfarandet
Kim et al. Advantages of using hairless mice versus haired mice to test sunscreen efficacy against photoimmune suppression¶
JPS57152423A (en) Treatment of electromagnetic steel plate
SE8104133L (sv) Bildning av ytmonster
FI972953A0 (fi) Menetelmä siirteen hylkäämisen estämiseksi
Beasley et al. Evaluation of an economical sunlamp that emits a near solar UV power spectrum for conducting photoimmunological and sunscreen immune protection studies
PT942978E (pt) Metodos para produzir o complexos promotor da anafase
ATE177867T1 (de) Digitaler sprachdekodierer unter verwendung einer nachfilterung mit einer reduzierten spektralverzerrung
AU7994891A (en) Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways
EP0138071A3 (de)
Ingram Some characteristics of delayed phonological systems.
SU694737A1 (ru) Способ контрол наличи пламени
Menzies et al. The augmentation of melanocytic nevi in guinea pigs by solar-simulated light: an animal model for human melanocytic nevi
Gu et al. Surface Densities of Murine Ia+ Dendritic Epidermal Cells (Ia+ DECs) and Thy‐1+ Dendritic Epidermal Cells (Thy‐1+ DECs) in Relationship to Aging and Ultraviolet B (UVB) Radiation
Tankov The effect of metabolites of the epidermal barrier on the development of phototoxic dermatitis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties